Treatment patterns and survival in men with metastatic castration-resistant prostate cancer (mCRPC): A systematic literature review of 35 real-world observational studies.

被引：0
|
作者：
Raval, Amit D.
Queen, V. Viji
Korn, Matthew J.
Quintero, Vanessa
Freedland, Stephen J.
机构：
[1] Bayer Healthcare Pharmaceut Inc, Whippany, NJ USA
[2] CapeStart Inc, Cambridge, MA USA
[3] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 5_SUPPL期
关键词：
D O I：
10.1200/JCO.2025.43.5_suppl.101
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Real-world use of systemic therapies in men with metastatic castration resistant prostate cancer (mCRPC) in Canada
    Shayegan, Bobby
    Wallis, Christopher J. D.
    Malone, Shawn
    Cagiannos, Ilias
    Hamilton, Robert J.
    Ferrario, Cristano
    Gotto, Geoffrey T.
    Basappa, Naveen S.
    Morgan, Scott C.
    Fernandes, Ricardo
    Morash, Christopher
    Niazi, Tamim
    Noonan, Krista L.
    Rendon, Ricardo
    Osborne, Brendan
    Park-Wyllie, Laura
    Chan, Katherine F. Y.
    Hotte, Sebastien J.
    Saad, Fred
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (05) : 192.e1 - 192.e9
  • [22] Real-world PROCEED registry data: Sipuleucel-T in elderly men with metastatic castration-resistant prostate cancer (mCRPC).
    Armstrong, Andrew J.
    Olsson, Carl A.
    Schnadig, Ian D.
    Concepcion, Raoul S.
    Vacirca, Jeffrey L.
    Tutrone, Ronald F.
    Dakhil, Shaker R.
    Chang, Nancy N.
    Tang, Hong
    Brown, Bruce
    Vogelzang, Nicholas J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [23] REAL-WORLD TREATMENT PATTERNS AND TREATMENT SEQUENCES IN THE METASTATIC CASTRATION-RESISTANT PROSTATE CANCER SETTINGS ACROSS EUROPE
    Castro, E.
    Orji, C.
    Ribbands, A.
    Butcher, J.
    Walley, M.
    Li, W.
    Ghate, S.
    VALUE IN HEALTH, 2024, 27 (06) : S227 - S227
  • [24] Treatment of metastatic castration-resistant prostate cancer (mCRPC) with enzalutamide
    Baciarello, Giulia
    Sternberg, Cora N.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 106 : 14 - 24
  • [25] Real-World Treatment Patterns and Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer in the US Prior to PARP Inhibitors
    Shore, Neal D.
    Laliberte, Francois
    Ionescu-Ittu, Raluca
    Yang, Lingfeng
    Mahendran, Malena
    Lejeune, Dominique
    Yu, Louise H.
    Burgents, Joseph
    Duh, Mei Sheng
    Ghate, Sameer R.
    ADVANCES IN THERAPY, 2021, 38 (08) : 4520 - 4540
  • [26] Real-World Treatment Patterns and Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer in the US Prior to PARP Inhibitors
    Neal D. Shore
    François Laliberté
    Raluca Ionescu-Ittu
    Lingfeng Yang
    Malena Mahendran
    Dominique Lejeune
    Louise H. Yu
    Joseph Burgents
    Mei Sheng Duh
    Sameer R. Ghate
    Advances in Therapy, 2021, 38 : 4520 - 4540
  • [27] Real-world treatment patterns and survival outcomes in men with metastatic castration-resistant prostate cancer in Finland: a national, population-based cohort study
    Rannikko, Antti
    Holsa, Olivia
    Agesen, Trude
    Ekman, Mattias
    Mattila, Riikka
    ACTA ONCOLOGICA, 2025, 64 : 173 - 178
  • [28] Real-world baseline treatment patterns and overall survival (rwOS) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with olaparib in the United States.
    Kariburyo-Yay, Furaha
    George, Daniel J.
    Aggarwal, Himani
    Tepsick, Jon G.
    Yu, Rebekah
    Li, Weiyan
    Orji, Chinelo
    Lal, Lincy S.
    Ghate, Sameer R.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [29] Real-world management of metastatic castration-resistant prostate cancer (mCRPC): A national multicenter cohort study.
    Lavallee, Luke
    Morash, Chris
    Saad, Fred
    Yip, Steven
    Kapoor, Anil
    Kolinsky, Michael Paul
    Pouliot, Frederic
    Antebi, Elie
    Drachenberg, Darrel
    Ferrario, Cristiano
    Gotto, Geoffrey
    Hamilton, Robert James
    Ko, Jenny J.
    Noonan, Krista
    So, Alan
    Malone, Shawn
    Zardan, Anousheh
    Chi, Kim N.
    Hotte, Sebastien J.
    Niazi, Tamim
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [30] Treatment of metastatic castration-resistant prostate cancer (mCRPC); Survival by type of progression at initiation of treatment
    Robbrecht, D. G.
    van Soest, R. J.
    Tannock, I. F.
    Oudard, S.
    Tombal, B.
    Eisenberger, M.
    Mercier, F.
    de Wit, R.
    ANNALS OF ONCOLOGY, 2018, 29
12345